{{Rsnum
|rsid=2072136
|Gene=OAS3
|Chromosome=12
|position=112961114
|Orientation=minus
|GMAF=0.3113
|Gene_s=LOC100287897,OAS3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.1 | 32.7 | 6.2
| HCB | 13.9 | 46.7 | 39.4
| JPT | 14.2 | 46.0 | 39.8
| YRI | 88.4 | 9.5 | 2.0
| ASW | 75.4 | 24.6 | 0.0
| CHB | 13.9 | 46.7 | 39.4
| CHD | 9.2 | 35.8 | 55.0
| GIH | 47.5 | 42.6 | 9.9
| LWK | 89.9 | 10.1 | 0.0
| MEX | 37.9 | 55.2 | 6.9
| MKK | 94.2 | 5.8 | 0.0
| TSI | 73.5 | 23.5 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21290821
|Title=[Polymorphism in the human 2'-5'-oligoadenylate synthetase genes (OAS), associated with predisposition to severe forms of tick-borne encephalitis, in populations from North Eurasia]
}}

{{PMID Auto
|PMID=15732009
|Title=Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.
|OA=1
}}

{{PMID Auto
|PMID=21050126
|Title=Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.
}}

{{PMID Auto
|PMID=23337612
|Title=Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}